Notice2022-02388
Notice of Closed Meeting
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
February 4, 2022
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 24 (Friday, February 4, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 24 (Friday, February 4, 2022)]
[Notices]
[Pages 6562-6563]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-02388]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended, and the Determination of the Director, Strategic
Business Initiatives Unit, Office of the Chief Operating Officer, CDC,
pursuant to Public Law 92-463. The grant applications and the
discussions could disclose confidential trade secrets or commercial
property such as patentable material, and personal information
concerning individuals associated with the grant applications, the
disclosure of which would constitute a clearly unwarranted invasion of
personal privacy.
Name of Committee: Disease, Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP): RFA-PS-22-001, Implementing Pre-
exposure Prophylaxis for HIV Prevention in Syringe Service Programs;
RFA-PS-22-002, Implementation Research on Telehealth Strategies to
Support Retention in Care and Treatment among Antiretroviral Therapy
(ART) Patients and Pre-exposure Prophylaxis (PrEP) Clients; and RFA-PS-
22-004, Understanding HIV/STD Risk and Enhancing PrEP Implementation
Messaging in a Diverse Community-Based Sample of Gay, Bisexual, and
Other Men Who Have Sex with Men in a Transformational Era.
Date: March 30, 2022.
Time: 10:00 a.m.-5:00 p.m., EDT.
Place: Teleconference.
Agenda: To review and evaluate grant applications.
For Further Information Contact: Gregory Anderson, M.S., M.P.H.,
Scientific Review Officer, CDC, National Center for HIV, Viral
Hepatitis, STD, and TB Prevention, 1600 Clifton Road, NE, Mailstop US8-
1, Atlanta, Georgia
[[Page 6563]]
30329, (404) 718-8833, <a href="/cdn-cgi/l/email-protection#a4e3e5cac0c1d6d7cbcae4c7c0c78ac3cbd2"><span class="__cf_email__" data-cfemail="9adddbf4feffe8e9f5f4daf9fef9b4fdf5ec">[email protected]</span></a>.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2022-02388 Filed 2-3-22; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on February 4, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.